|Real-time Estimate - 10/28 02:32:57 pm|
NEKTAR THERAPEUTICS : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
|08/06/2020 | 05:24pm|
Item 2.02 Results of Operations and Financial Condition.
issued a press release (the "Press Release") announcing its financial results
for the quarter ended
herewith as Exhibit 99.1.
home page and Investors section of the Nektar website: http://ir.nektar.com.
The information in this report, including the exhibit hereto, is being furnished
and shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of
that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as
amended. The information contained herein and in the accompanying exhibit shall
not be incorporated by reference into any filing with the
the date hereof, regardless of any general incorporation language in such
Item 9.01 Financial Statements and Exhibits.
Exhibit No. Description
99.1 Press release titled "Nektar Therapeutics Reports Second Quarter 2020
Financial Results" issued by
© Edgar Online, source